Time-to-progression in breast cancer: A stratification model for clinical trials-Reference-Cited by-同舟云学术

Time-to-progression in breast cancer: A stratification model for clinical trials

Published:2008-06 Issue:3 Volume:17 Page:239-244
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

de la Haba-Rodríguez Juan,Aranda Enrique,Llombart Antonio,Lluch Ana,Alba Emilio,Munárriz Blanca,Adrover Encarna,Tusquets Ignacio,Balil Ana,Barnadas Agustí,Calvo Lourdes,Martín Miguel

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference26 articles.

1. There are no bad anticancer agents, only bad clinical trial designs: Twenty First Richard and Linda Rosenthal Foundation Award Lecture;von Hoff;Clin Cancer Res,1998

2. Anticancer agents targeting signalling molecules and cancer cell environment: challenges for drug development?;Gelmon;J Natl Cancer Inst,1999

3. The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors;Kamby;Cancer Treat Rev,1990

4. Relation between the pathological nature and the growth rate of human tumors;Charbit;Eur J Cancer,1971

5. Growth rate of 147 mammary carcinomas;Fournier;Cancer,1980

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of the Impact of COVID-19 Pandemic Lockdowns on Breast Cancer Deaths and Costs in Poland Using Markovian Monte Carlo Simulation;Computational Science – ICCS 2023;2023

2. Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register;Breast Cancer Research and Treatment;2010-01-10